<DOC>
	<DOCNO>NCT01773174</DOCNO>
	<brief_summary>Study ass PK/PD parameter safety tolerability study medication age group</brief_summary>
	<brief_title>Pharmacokinetics , Safety Tolerability Dabigatran Etexilate Solution Children 1 &lt; 2 Years Age</brief_title>
	<detailed_description />
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Dabigatran</mesh_term>
	<criteria>Inclusion criterion : 1. male females 1 less 2 year age 2. objective diagnosis primary venous thromboembolism 3. completion plan treatment course low molecular weight heparin oral anticoagulant primary venous thromboembolism 4. write informed consent parent ( legal guardian ) patient assent ( applicable ) Exclusion criterion : 1. weight less 9 kg 2. condition associate increase risk bleed 3. patient condition would allow safe participation study Note : Further exclusion criterion apply</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>2 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>